Applicant, as named in the Orange Book

Neurocrine

Next listed expiry: Ingrezza on 10 Aug 2040. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ingrezza · 3 strengths valbenazine tosylate	valbenazine tosylate	209241	10 Aug 2040	patent, carve-out possible
Ingrezza Sprinkle · 3 strengths valbenazine tosylate	valbenazine tosylate	218390	10 Aug 2040	patent, carve-out possible
Crenessity · 3 strengths crinecerfont	crinecerfont	218808	12 Jan 2043	patent
Crenessity crinecerfont	crinecerfont	218820	12 Jan 2043	patent